PPD DEVELOPMENT LP: federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2023 (FY2024), from USAspending.gov. UEI: ZANENSW6C665
27contracts won
$979,403,628total obligated
$2,773,098median contract
Jun 29, 2026most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Health and Human Services | 27 | $979,403,628 |
Industries (NAICS)
| NAICS | Contracts | Obligated |
|---|---|---|
| 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) | 6 | $471,896,278 |
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | 8 | $302,208,297 |
| 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 7 | $167,332,570 |
| 541711 Research and development in biotechnology | 2 | $32,732,153 |
| 541690 Other Scientific and Technical Consulting Services | 1 | $2,054,175 |
| 541990 All Other Professional, Scientific, and Technical Services | 2 | $1,880,937 |
| 541720 Research and Development in the Social Sciences and Humanities | 1 | $1,299,218 |
Where it works
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CT
75N98026F00001 · NAICS 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$2,016,831 Potential value: $5,053,689 |
Jun 29, 2026 Ends: Apr 28, 2027 |
| DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX)
75N93026F00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$3,092,829 Potential value: $21,599,356 |
Dec 15, 2025 Ends: Dec 14, 2026 |
| BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS.
75F40124C00134 · NAICS 541720 Research and Development in the Social Sciences and Humanities · Wilmington, NC |
— | Department of Health and Human Services Food and Drug Administration |
$1,299,218 | Sep 24, 2024 Ends: Nov 22, 2027 |
| FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASURE
75F40124C00117 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Wilmington, NC |
— | Department of Health and Human Services Food and Drug Administration |
$724,461 | Sep 11, 2024 Ends: Jul 15, 2027 |
| COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)
75N93024F00002 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$26,101,778 Potential value: $75,173,993 |
Aug 15, 2024 Ends: Aug 14, 2027 |
| PHASE I RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS
75N95024F00002 · NAICS 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$305,772 Potential value: $3,358,776 |
Jul 15, 2024 Ends: Jun 30, 2026 |
| RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. CLINICAL STUDY PROTOCOL DEVELOPMENT. TASK ORDER 02. 06/17/2024 - 06/…
75N95024F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$324,420 | Jun 17, 2024 Ends: Jun 16, 2029 |
| REGULATORY CONSULTING ASSISTANCE FOR MEDICAL DEVICE DEVELOPER. RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. PRE-S…
75N95024F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$370,621 | Apr 09, 2024 Ends: Apr 08, 2029 |
| NIAID CLINICAL SITE MONITORING (NCSM)
75N93024F00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$73,196,564 Potential value: $186,449,775 |
Feb 01, 2024 Ends: Jan 31, 2027 |
| BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY…
75A50124C00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Wilmington, NC |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$117,399,278 Potential value: $222,126,308 |
Dec 15, 2023 Ends: Sep 30, 2030 |
| ADVANCED RESEARCH AND DEVELOPMENT ACTIVITIES FOR NOVEL IMMUNOGENICITY ASSAYS AND SAMPLE COLLECTION TECHNOLOGIES AS PART OF BARDA?S CONTINUIN…
75A50123C00045 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Wilmington, NC |
— | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$126,485,055 | Sep 29, 2023 Ends: Sep 28, 2029 |
| ASSESSING CLINICAL SITE READINESS: A FRAMEWORK TO SUPPORT ENROLLMENT OF UNDER-REPRESENTED MINORITIES IN MEDICAL DEVICE CLINICAL TRIALS (FY23…
75F40123C00198 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Wilmington, NC |
— | Department of Health and Human Services Food and Drug Administration |
$235,056 Potential value: $563,173 |
Sep 27, 2023 Ends: Jul 20, 2024 |
| REGULATORY CONSULTING ASSISTANCE FOR MEDICAL DEVICE DEVELOPER. RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. TASK…
75N95023F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$63,603 | Sep 15, 2023 Ends: Dec 31, 2024 |
| EPCTU
75N93023F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$2,791,811 | Jun 29, 2023 Ends: Jan 31, 2026 |
| "COVID 19"COMPLETION OF ACTIV 2 STUDY
75N93022F00002 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$64,031,927 | Nov 06, 2022 Ends: Aug 31, 2025 |
| CLINICAL RESEARCH AND STUDY MONITORING SUPPORT FOR NIMH STUDIES
75N95022C00036 · NAICS 541990 All Other Professional, Scientific, and Technical Services · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$1,226,376 | Sep 28, 2022 Ends: May 15, 2025 |
| NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC)
75N93022C00014 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$36,391,559 | Jun 30, 2022 Ends: Jun 29, 2027 |
| TASK ORDER 75N93022F00001 BASE AWARD
75N93022F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$905,501 Potential value: $1,859,402 |
Jan 14, 2022 Ends: Jan 13, 2027 |
| REGULATORY MANAGEMENT CENTER (RMC)
75N93022C00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$17,426,404 Potential value: $29,120,381 |
Nov 01, 2021 Ends: Oct 31, 2026 |
| TBTC MONITORING
75D30121C11269 · NAICS 541690 Other Scientific and Technical Consulting Services · Wilmington, NC |
— | Department of Health and Human Services Centers for Disease Control and Prevention |
$2,054,175 | Jun 10, 2021 Ends: Jun 27, 2024 |
| BUCKPITT-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19186 (EC5026) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL M…
75N95019F00089 · NAICS 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$1,820,177 Potential value: $2,048,932 |
Jul 01, 2019 Ends: Mar 10, 2025 |
| ACQUISITION TITLE: CLINICAL SITE AND STUDY MONITORING SUPPORT SERVICES FOR THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE'S HYPERTENSION OUTC…
75N92019C00005 · NAICS 541990 All Other Professional, Scientific, and Technical Services · Bethesda, MD |
— | Department of Health and Human Services National Institutes of Health |
$654,561 | Apr 25, 2019 Ends: Jul 25, 2023 |
| TO PROVIDE MONITORING SERVICES FOR ONE (1) PHASE III CLINICAL TRIAL, A5300B/PHOENIX
75N93019F00131 · NAICS 541711 Research and development in biotechnology · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$5,696,077 | Apr 15, 2019 Ends: Dec 14, 2025 |
| IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)
HHSN272201700078C · NAICS 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$329,835,681 Potential value: $332,437,172 |
Aug 14, 2017 Ends: Aug 14, 2024 |
| IGF::OT::IGF NIAID CLINICAL SITE MONITORING
HHSN272201700004C · NAICS 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) · Wilmington, NC |
— | Department of Health and Human Services National Institutes of Health |
$135,144,719 Potential value: $139,861,060 |
Jan 31, 2017 Ends: Jan 31, 2024 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.